Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
9.82
Facility
$674.03
Non-Facility
$674.03
Documentation Required
Use of intra-operative/intra-wound vancomycin powder: document dosing/administration, indication, baseline infection risk factors, and post-operative monitoring for wound complications, AKI, ototoxicity (authors reported no statistical difference but monitored these endpoints).
When using TXA: documentation of procedure type (primary THA), route and dosing of TXA (intravenous, topical, or combined), and exclusion/consideration if revision THA or hip fracture surgery (VHA: evidence lacking in revisions/hip fracture).
Robotic or navigation-assisted THA: pre-operative target angles, intra-operative navigation records (intra-operative cup angles using navigation records), and post-operative imaging to verify cup orientation (post-operative CT data or radiographs) as used in the cited studies (e.g., HipAlign intra-op records vs post-op CT comparisons).
Key Coverage Criteria
Progressive or substantial periprosthetic bone loss confirmed by imaging;
Outside-in arthroscopic psoas release for anterior iliopsoas impingement after primary total hip arthroplasty
Fracture or mechanical failure of 1 or more components of the prosthesis confirmed by imaging;
Confirmed periprosthetic infection confirmed by gram stain and culture;
Displaced periprosthetic fracture confirmed by imaging;
Bearing surface wear leading to symptomatic synovitis or local bone or soft tissue reaction;
Ask Verity about documentation requirements, denial risks, or coverage in your state.
For diagnosis and management of iliopsoas impingement: documentation of careful history, physical examination, laboratory evaluation, diagnostic imaging (X-rays and pelvic CT scans), and diagnostic local anesthetic/infiltration test results prior to performing tenotomy; if tenotomy performed, document site (lesser trochanter or acetabular rim), technique, and pre- and post-operative PROs (HHS, WOMAC, Oxford Hip Score, mHHS) where available.
For custom-made acetabular implants: documentation of Paprosky classification of acetabular deficiency (e.g., Type IIIA/IIIB), CT-based pre-operative planning, rationale for custom implant, and post-operative radiographic/CT assessment of implant position and fixation.
For thromboprophylaxis decisions: documentation of chosen agent and regimen (aspirin, LMWH, enoxaparin, rivaroxaban), indications and contraindications, and informed discussion reflecting current evidence (e.g., CRISTAL results favoring enoxaparin over aspirin for symptomatic VTE prevention).